TITAN PHARMACEUTICALS INC·4

Sep 25, 7:06 PM ET

BHONSLE SUNIL 4

4 · TITAN PHARMACEUTICALS INC · Filed Sep 25, 2018

Insider Transaction Report

Form 4
Period: 2018-09-21
BHONSLE SUNIL
DirectorPresident
Transactions
  • Purchase

    Common Stock

    2018-09-21$0.25/sh+300,000$75,000435,578 total
  • Award

    Warrants

    2018-09-21+300,000300,000 total
    Exercise: $0.25From: 2023-09-25Exp: 2023-09-25common stock (300,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    54,684
Footnotes (1)
  • [F1]The reporting person serves as trustee of the family trust.

Documents

1 file
  • 4
    tv503427_4.xmlPrimary

    OWNERSHIP DOCUMENT